Comparative Outcomes of Drug-Eluting Stents and Drug-Coated Balloons Following Rotablator Atherectomy for Calcified Coronary Lesions

Comparative Outcomes of Drug-Eluting Stents and Drug-Coated Balloons Following Rotablator Atherectomy for Calcified Coronary Lesions - Comparative Outcomes of Drug-Eluting Stents and Drug-Coated Balloons Following Rotablator Atherectomy for Calcified Coronary Lesions

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000057688

Enrollment

710

Registered

2025-04-23

Start date

2020-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

angina pectoris

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1,Underwent PCI with either drug-coated balloon angioplasty or second-generation drug-eluting stent implantation (stent diameter under 3mm). 2,Received rotational atherectomy before balloon dilatation.

Exclusion criteria

Exclusion criteria: 1,Presence of in-stent restenosis. 2,Acute coronary syndrome.

Design outcomes

Primary

Measure	Time frame
The primary endpoint is the cumulative one-year incidence of major adverse cardiovascular events, defined as a composite of cardiac death, clinically driven TVR or TLR, and target vessel myocardial infarction.	—

Countries

Japan

Contacts

Public ContactHisanori Yui

Sapporo Cardiovascular Clinic Department of Cardiovascular Medicine

hyui@shinshu-u.ac.jp08051435751

Outcome results